FDA Advisors Endorse Moving Naloxone Over the Counter

(MedPage Today) -- Advisors to the FDA unanimously recommended the agency approve the first over-the-counter (OTC) naloxone (Narcan) product, though many committee members expressed continued concern about user instructions for the opioid overdose...
Source: MedPage Today Neurology - Category: Neurology Source Type: news
More News: Brain | Neurology | Overdose